AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Nichi-Iko Pharmaceutical Co., Ltd.
  3. Financials
  4. Diluted EPS

Nichi-Iko Pharmaceutical Co., Ltd.【JP:E00963】

Market cap
P/E ratio
SummaryFinancialsDividendsHistorySegmentsWorkforce
Period EndDiluted EPS (JPY)YoY (%)
Mar 31, 2022-1,554.4+2281.08%
Mar 31, 2021-65.3-181.46%
Mar 31, 202080.1-29.73%
Mar 31, 2019114+66.82%
Mar 31, 201868.4-18.57%
Mar 31, 201784-54.38%
Mar 31, 2016184+67.08%
Mar 31, 2015110.1+5.23%
Mar 31, 2014104.7-18.28%
Mar 31, 2013128.1+26.15%
Nov 30, 2011101.5

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)